Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter

Abstract

Objective: Aquaporin 4 (AQP4)‐specific autoantibodies in neuromyelitis optica (NMO) are immunoglobulin (Ig)G1, a T cell‐dependent Ig subclass, indicating that AQP4‐specific T cells participate in NMO pathogenesis. Our goal was to identify and characterize AQP4‐specific T cells in NMO patients and healthy controls (HC). Methods: Peripheral blood T cells from NMO patients and HC were examined for recognition of AQP4 and production of proinflammatory cytokines. Monocytes were evaluated for production of T cell‐polarizing cytokines and expression of costimulatory molecules. Results: T cells from NMO patients and HC proliferated to intact AQP4 or AQP4 peptides (p11–30, p21–40, p61–80, p131–150, p156–170, p211–230, and p261–280). T cells from NMO patients demonstrated greater proliferation to AQP4 than those from HC, and responded most vigorously to p61–80, a naturally processed immunodominant determinant of intact AQP4. T cells were CD4 + , and corresponding to association of NMO with human leukocyte antigen (HLA)‐DRB1*0301 and DRB3, AQP4 p61–80‐specific T cells were HLA‐DR restricted. The T‐cell epitope within AQP4 p61–80 was mapped to 63–76, which contains 10 residues with 90% homology to a sequence within Clostridium perfringens adenosine triphosphate‐binding cassette (ABC) transporter permease. T cells from NMO patients proliferated to this homologous bacterial sequence, and cross‐reactivity between it and self‐AQP4 was observed, supporting molecular mimicry. In NMO, AQP4 p61–80‐specific T cells exhibited Th17 polarization, and furthermore, monocytes produced more interleukin 6, a Th17‐polarizing cytokine, and expressed elevated CD40 and CD80 costimulatory molecules, suggesting innate immunologic dysfunction. Interpretation: AQP4‐specific T‐cell responses are amplified in NMO, exhibit a Th17 bias, and display cross‐reactivity to a protein of an indigenous intestinal bacterium, providing new perspectives for investigating NMO pathogenesis. ANN NEUROL 2012;

Shown for reading. Its publisher allows quoting it, not republishing it.

References 50

1. 1.
   Neuromyelitis optica pathogenesis and aquaporin 4 · 2008

   No notice
2. 2.

   Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473-477.

   Not in our library10.1084/jem.20050304

3. 3.

   Nurieva RI, Chung Y. Understanding the development and function of T follicular helper cells. Cell Mol Immunol. 2010;7:190-197.

   Not in our library10.1038/cmi.2010.24

4. 4.

   Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66:617-629.

   Not in our library10.1002/ana.21802

5. 5.

   Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009;66:630-643.

   Not in our library10.1002/ana.21837

6. 6.

   Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(pt 7):1450-1461.

   Not in our library10.1093/brain/awf151

7. 7.

   Uzawa A, Mori M, Arai K, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler. 2010;16:1443-1452.

   Not in our library10.1177/1352458510379247

8. 8.

   Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485-1489.

   Not in our library10.1212/01.wnl.0000216139.44259.74

9. 9.

   Jacob A, Weinshenker BG, Violich I, et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008;65:1443-1448.

   Not in our library10.1001/archneur.65.11.noc80069

10. 10.

    Ho JD, Yeh R, Sandstrom A, et al. Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance. Proc Natl Acad Sci U S A. 2009;106:7437-7442.

    Not in our library10.1073/pnas.0902725106

11. 11.
    Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method · 2007

    No notice
12. 12.
    NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction · 2009

    No notice
13. 13.

    Zamvil SS, Mitchell DJ, Moore AC, et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature. 1986;324:258-260.

    Not in our library10.1038/324258a0

14. 14.

    Owens G, Ritchie A, Lam C, Bennett J. Mutagenesis of aquaporin-4 extracellular domains defines binding patterns of neuromyelitis optica intrathecal IgG. Mult Scler. 2011;17(10 suppl):S291-S292.

    Not in our library

15. 15.

    Mannering SI, Morris JS, Jensen KP, et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods. 2003;283:173-183.

    Not in our library10.1016/j.jim.2003.09.004

16. 16.

    Nelson PA, Khodadoust M, Prodhomme T, et al. Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica. PLoS One. 2010;5:e15050.

    Not in our library10.1371/journal.pone.0015050

17. 17.

    Kalluri SR, Rothhammer V, Staszewski O, et al. Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica. PLoS One. 2011;6:e16083.

    Not in our library10.1371/journal.pone.0016083

18. 18.

    Slavin AJ, Soos JM, Stuve O, et al. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest. 2001;108:1133-1139.

    Not in our library10.1172/jci13360

19. 19.

    Soos JM, Morrow J, Ashley TA, et al. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J Immunol. 1998;161:5959-5966.

    Not in our library

20. 20.

    Zamvil S, Nelson P, Trotter J, et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature. 1985;317:355-358.

    Not in our library10.1038/317355a0

21. 21.

    Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol. 2008;8:607-618.

    Not in our library10.1038/nri2368

22. 22.

    Matsushita T, Matsuoka T, Isobe N, et al. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens. 2009;73:171-176.

    Not in our library10.1111/j.1399-0039.2008.01172.x

23. 23.

    Brum DG, Barreira AA, dos Santos AC, et al. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult Scler. 2010;16:21-29.

    Not in our library10.1177/1352458509350741

24. 24.

    Deschamps R, Paturel L, Jeannin S, et al. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population. Mult Scler. 2011;17:24-31.

    Not in our library10.1177/1352458510382810

25. 25.

    Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985;230:1043-1045.

    Not in our library10.1126/science.2414848

26. 26.

    Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995;80:695-705.

    Not in our library10.1016/0092-8674(95)90348-8

27. 27.

    Warabi Y, Yagi K, Hayashi H, Matsumoto Y. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis. J Neurol Sci. 2006;249:145-152.

    Not in our library10.1016/j.jns.2006.06.011

28. 28.

    Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8:942-949.

    Not in our library10.1038/ni1496

29. 29.

    Katzman SD, Gallo E, Hoyer KK, Abbas AK. Differential requirements for Th1 and Th17 responses to a systemic self-antigen. J Immunol. 2011;186:4668-4673.

    Not in our library10.4049/jimmunol.1003786

30. 30.

    Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995;80:707-718.

    Not in our library10.1016/0092-8674(95)90349-6

31. 31.

    Benjamin DC, Berzofsky JA, East IJ, et al. The antigenic structure of proteins: a reappraisal. Annu Rev Immunol. 1984;2:67-101.

    Not in our library10.1146/annurev.iy.02.040184.000435

32. 32.

    Weber MS, Prod'homme T, Patarroyo JC, et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol. 2010;68:369-383.

    Not in our library10.1002/ana.22081

33. 33.

    Kaushansky N, Zhong MC, Kerlero de Rosbo N, et al. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J Immunol. 2006;177:7364-7376.

    Not in our library10.4049/jimmunol.177.10.7364

34. 34.

    Morita R, Schmitt N, Bentebibel SE, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34:108-121.

    Not in our library10.1016/j.immuni.2010.12.012

35. 35.

    Popescu BF, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011;76:1229-1237.

    Not in our library10.1212/wnl.0b013e318214332c

36. 36.

    Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13:1173-1175.

    Not in our library10.1038/nm1651

37. 37.

    Huppert J, Closhen D, Croxford A, et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J. 2010;24:1023-1034.

    Not in our library10.1096/fj.09-141978

38. 38.

    Roussel L, Houle F, Chan C, et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol. 2010;184:4531-4537.

    Not in our library10.4049/jimmunol.0903162

39. 39.

    Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538-541.

    Not in our library10.1038/nature10554

40. 40.

    Ochoa-Reparaz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol. 2011;69:240-247.

    Not in our library10.1002/ana.22344

41. 41.
    NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure · 2010

    No notice
42. 42.

    Lindstrom M, Heikinheimo A, Lahti P, Korkeala H. Novel insights into the epidemiology of Clostridium perfringens type A food poisoning. Food Microbiol. 2011;28:192-198.

    Not in our library10.1016/j.fm.2010.03.020

43. 43.

    Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485-498.

    Not in our library10.1016/j.cell.2009.09.033

44. 44.

    Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337-341.

    Not in our library10.1126/science.1198469

45. 45.

    Lindsey JW, Meulmester KM, Brod SA, et al. Variable results after rituximab in neuromyelitis optica. J Neurol Sci. 2012;317:103-105.

    Not in our library10.1016/j.jns.2012.02.017

46. 46.

    Axtell RC, Raman C, Steinman L. Interferon-beta exacerbates Th17-mediated inflammatory disease. Trends Immunol. 2011;32:272-277.

    Not in our library10.1016/j.it.2011.03.008

47. 47.

    Warabi Y, Matsumoto Y, Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci. 2007;252:57-61.

    Not in our library10.1016/j.jns.2006.10.008

48. 48.

    Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010;75:1423-1427.

    Not in our library10.1212/wnl.0b013e3181f8832e

49. 49.

    Palace J, Leite MI, Nairne A, Vincent A. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010;67:1016-1017.

    Not in our library10.1001/archneurol.2010.188

50. 50.

    Crane JM, Tajima M, Verkman AS. Live-cell imaging of aquaporin-4 diffusion and interactions in orthogonal arrays of particles. Neuroscience. 2010;168:892-902.

    Not in our library10.1016/j.neuroscience.2009.08.034

Cited by papers we hold 8

• Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in Chinese adults: a cross-sectional study · 2022
  Not checked
• Microbial dysbiosis in the gut drives systemic autoimmune diseases · 2022
  No notice
• Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder · 2021
  Not checked
• Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies · 2021
  No notice
• Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity · 2020
  No notice
• Emerging Role of Diet and Microbiota Interactions in Neuroinflammation · 2018
  Not checked
• Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases · 2018
  No notice
• Alterations of the human gut microbiome in multiple sclerosis · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.